Botein dual-load ADC IND successfully delivered

According to a statement from Bonten Pharmaceuticals, recently, Bonten's one-stop protein and antibody-drug conjugate (ADC) CDMO platform successfully completed the development of dual payload ADC process and the delivery of GMP IND clinical samples, covering core processes including Payload-Linker, antibody, ADC research and development, production, etc. The complete process service from process development to release of registered samples has been successfully implemented. The successful delivery of the dual payload ADC IND clinical samples fully validates Bonten's platform's technical strength in the field of complex conjugate drugs.